Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Trophic factor combinations for nervous system treatment

a technology of trophic factor and combination, which is applied in the field of neurochemically active agent combinations for nervous system treatment, can solve the problems of traumatic injury, multiple injuries to the nervous system, and traumatic injury

Inactive Publication Date: 2007-09-06
WISCONSIN ALUMNI RES FOUND
View PDF1 Cites 60 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The invention provides a composition that includes an antimicrobial peptide and / or a substance with antimicrobial peptide effect, as well as a neurotrophin. The composition can be used to treat injuries to the nervous system of an animal. The method involves identifying the injury and applying the composition to the injury. The kit includes the antimicrobial peptide and / or substance with antimicrobial peptide effect, as well as a neurotrophin and / or a viscous substance. The technical effect of the invention is to provide a composition that can effectively treat injuries to the nervous system of an animal while preventing infection.

Problems solved by technology

The nervous system can be injured in numerous ways, and injuries can be traumatic.
For instance, sudden physical assault on a portion of the nervous system results in a traumatic injury.
This puts pressure on the brain, which can lead to changes in brain function.
With spinal cord injuries in the neck, significant impairment of breathing may result.
The most frequent site of spinal injury is the neck or cervical region and, of these, the major cause of death arises from respiratory complications.
For others with less severe respiratory impairment, they may be able to breathe normally, but are unable to sigh or breathe deeply and maintain the integrity of the lung.
Injury to the spinal cord and other parts of the nervous system may be particularly devastating to life and the quality of life.
In addition, injury to the nervous system can engender serious economic losses to the individual and to society.
Currently, there are few effective treatment options available for patients with spinal cord injuries, although there are a few promising indications that physical therapy or chronic intermittent hypoxia (CIH), may have beneficial effects.
However, studies have also shown that chronic intermittent hypoxia has other drawbacks as a treatment for spinal cord injuries.
For example, certain CIH treatment methods can cause systemic hypertension, altered sympathetic chemoreflexes, and hippocampal cell death by the process of apoptosis.
Unfortunately, this type of therapy is very expensive, and efficacy is far from complete.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Trophic factor combinations for nervous system treatment
  • Trophic factor combinations for nervous system treatment
  • Trophic factor combinations for nervous system treatment

Examples

Experimental program
Comparison scheme
Effect test

example 1

Materials and Methods

[0111] Experiments were performed on 3-5 month old male Sprague-Dawley (SD) and Lewis rats that were housed individually with free access to food and water. Rats were placed into four groups: 1) spinally injured SD rats without a trophic factor combination administered (n=8), 2) spinally injured SD rats with a trophic factor combination (n=2); 3) spinally injured Lewis rats without a trophic factor combination administered (n=5), and 4) spinally injured Lewis rats with a trophic factor combination administered (n=2).

[0112] Spinal cord injury. Rats were anesthetized with medetomidine (75 μg / kg i.m.) and isoflurane in oxygen. After oro-tracheal intubation, anesthesia was maintained with isoflurane in oxygen and rats were mechanically ventilated. A laminectomy was made at the second cervical vertebral level to allow the second cervical spinal segment and the cranial segment of the third cervical spinal segment to be exposed. A 1-mm-long left-sided hemisection wa...

example 2

[0123] This study was performed to determine whether application of a trophic factor combination can improve motor function after spinal cord injury (SCI). In this study, the trophic factor combination of Example 1 was applied and included insulin-like growth factor (IGF-1), brain-derived neurotrophic factor (BDNF), bactenesin (BNP-1), and substance P. The trophic factor combination was applied to test whether this combination would augment spontaneous respiratory motor recovery in a well-defined model of high cervical incomplete spinal cord injury (C2 hemisection). The trophic factor combination was applied to the injured spinal cord at the time of surgical injury. At 2 weeks post-injury, respiratory motor output was recorded bilaterally from phrenic nerves in urethane anesthetized, vagotomized, and mechanically ventilated spinally injured Lewis male rats (SCI-only: n=6; SCI+ trophic factor combination; n=6, with some of these rats being the same as the rats in Example 1). Body wei...

example 3

[0124] Subtractive studies. Experiments can be performed on rats in accordance with the methods described in Example 2 except that fewer than all four components, i.e., insulin-like growth factor (IGF-1), brain-derived neurotrophic factor (BDNF), bactenesin (BNP-1), and substance P, of the trophic factor combination can be used (except for one or more controls using all four components). Different components can also be used. For example, a different growth factor (and / or neurotrophin and / or neuropeptide and / or antimicrobial peptide) can be used than the one listed above. Studies can also be run using only one component, i.e., either IGF-1, BDNF, BNP-1, or substance P or any other trophic factor to determine the effects of the individual components. Studies can also be performed using combinations of two of the components and using combinations of three of the components to determine whether all four components are needed to achieve the desired results.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
viscousaaaaaaaaaa
compositionaaaaaaaaaa
neuronal plasticityaaaaaaaaaa
Login to View More

Abstract

The present invention relates to a composition including an effective amount of at least one of an antimicrobial peptide and a substance having an antimicrobial peptide effect and an effective amount of a neurotrophin. The composition can also include an effective amount of at least one of a growth factor and a neuropeptide. The present invention also relates a method of treating an injury to a nervous system of an animal that includes the steps of identifying the injury to the nervous system and applying to the injury an effective amount of at least one of antimicrobial peptide and a substance having an antimicrobial peptide effect. The method can also include applying an effective amount of one or more trophic factors selected from the group consisting of a growth factor, a neurotrophin, and a neuropeptide to the injury.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] This application claims priority under 35 U.S.C. §119(e) to U.S. Provisional Patent Application No. 60 / 604,912, filed Aug. 27, 2004, the entirety of which is incorporated by reference herein.REFERENCE TO GOVERNMENT GRANT [0002] This invention was made with United States government support awarded by the National Institutes of Health, Grant # HL069064. The United States has certain rights in this invention.FIELD OF THE INVENTION [0003] The invention relates to combinations of neurochemically active agents for treating a nervous system and the methods of treating a nervous system with the combinatorial treatments. BACKGROUND OF THE INVENTION [0004] The nervous system is comprised of two divisions: the central nervous system (CNS) and the peripheral nervous system (PNS). The CNS includes the brain and the spinal cord and controls most functions of the body and mind. The remainder of the nervous system is the PNS. Nerves of the PNS connect ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/18A61K38/17A61K9/14
CPCA61K9/06A61K38/185A61K38/30A61K38/1709A61K38/046A61L2300/414A61L2300/404A61L2300/252A61L27/54A61L27/52A61K2300/00
Inventor MURPHY, CHRISTOPHER J.MCANULTY, JONATHAN F.MITCHELL, GORDON S.GOLDER, FRANCIS J.
Owner WISCONSIN ALUMNI RES FOUND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products